WA
WST icon

WPG Advisers’s West Pharmaceutical WST Stock Holding History

WPG Advisers’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.46K Hold
18
– – ﹤0.01% 898
2026
Q1 		$4.51K Hold
18
– – ﹤0.01% 909
2025
Q4 		$4.95K Sell
18
-18
-50% -$4.92K ﹤0.01% 909
2025
Q3 		$9.44K Buy
36
+18
+100% +$4.38K 0.01% 709
2025
Q2 		$3.94K Sell
18
-2
-10% -$428 ﹤0.01% 953
2025
Q1 		$4.48K Sell
20
-3
-13% -$827 ﹤0.01% 910
2024
Q4 		$7.53K Buy
+23
New +$7.24K 0.01% 715

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
BTCPP
Border to Coast Pensions Partnership Leeds, United Kingdom $6.78B AUM 31.6% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return

WPG Advisers's WST Position: Q2 2026 in Review

WPG Advisers held its West Pharmaceutical (WST) position steady in Q2 2026 at 18 shares worth $6.46K. The position accounts for ﹤0.01% of the portfolio, ranked #898.

WPG Advisers first reported a position in WST in Q4 2024 and has held it in 7 quarters since. The position peaked at $9.44K in Q3 2025. 426 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • WPG Advisers held 18 shares of West Pharmaceutical worth $6.46K as of Q2 2026.
  • WPG Advisers left its West Pharmaceutical share count unchanged in Q2 2026.
  • West Pharmaceutical made up ﹤0.01% of WPG Advisers's portfolio in Q2 2026, its #898 holding.
  • WPG Advisers first reported a position in West Pharmaceutical in Q4 2024 and has held it in 7 quarters since.
  • WPG Advisers's West Pharmaceutical position peaked at $9.44K in Q3 2025.
  • 426 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on WPG Advisers's 13F filing for Q2 2026, filed 6 Aug 2026.